Inicio
Resultado de la búsqueda
2 búsqueda de la palabra clave 'SARS-CoV2'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Pericarditis aguda asociada a infección por COVID-19 / Jhon Edwar García Rueda ; Ana María Caicedo Bolaños ; Luz Adriana Gómez Ramírez ; Jorge Ricardo Sánchez Madrid
Título : Pericarditis aguda asociada a infección por COVID-19 Otros títulos : Acute pericarditis associated with COVID-19 infection Tipo de documento : documento electrónico Autores : Jhon Edwar García Rueda, ; Ana María Caicedo Bolaños, ; Luz Adriana Gómez Ramírez, ; Jorge Ricardo Sánchez Madrid, Fecha de publicación : 2022 Títulos uniformes : Iatreia Idioma : Español (spa) Palabras clave : COVID-19 Pericarditis SARS-CoV2 Resumen : La infección por el coronavirus de tipo 2 causante del síndrome respiratorio agudo grave (SARS-COV2, por sus siglas en inglés), ha sido asociada con múltiples manifestaciones cardiovasculares. El mecanismo por el cual el virus afecta el corazón es objeto de discusión; sin embargo, se ha planteado que el receptor de la enzima convertidora de angiotensina (ACE2) sirve como entrada directa del virus. Así mismo, un estado de inflamación mediado por una tormenta de citoquinas puede generar falla multiorgánica y explicar algunas manifestaciones cardíacas. Las principales asociaciones al sistema cardiovascular reportadas en la infección por COVID-19 son el síndrome coronario agudo, la falla cardiaca aguda, el choque cardiogénico y las arritmias. La pericarditis aguda es un síndrome inflamatorio de etiología principalmente viral, pero su relación con la infección por SARS-COV2 parece ser infrecuente, con pocos reportes en la literatura. Se presenta el caso de una paciente que desarrolló pericarditis concomitante a la infección por SARS-COV2. Mención de responsabilidad : Jhon Edwar García-Rueda, Ana María Caicedo-Bolaños, Luz Adriana Gómez-Ramírez, Jorge Ricardo Sánchez-Madrid Referencia : Iatreia ; 35(1):74-78, 2022. DOI (Digital Object Identifier) : 10.17533/udea.iatreia.130 Derechos de uso : CC BY-NC-SA En línea : https://revistas.udea.edu.co/index.php/iatreia/article/view/345585 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5819 Pericarditis aguda asociada a infección por COVID-19 = Acute pericarditis associated with COVID-19 infection [documento electrónico] / Jhon Edwar García Rueda, ; Ana María Caicedo Bolaños, ; Luz Adriana Gómez Ramírez, ; Jorge Ricardo Sánchez Madrid, . - 2022.
Obra : Iatreia
Idioma : Español (spa)
Palabras clave : COVID-19 Pericarditis SARS-CoV2 Resumen : La infección por el coronavirus de tipo 2 causante del síndrome respiratorio agudo grave (SARS-COV2, por sus siglas en inglés), ha sido asociada con múltiples manifestaciones cardiovasculares. El mecanismo por el cual el virus afecta el corazón es objeto de discusión; sin embargo, se ha planteado que el receptor de la enzima convertidora de angiotensina (ACE2) sirve como entrada directa del virus. Así mismo, un estado de inflamación mediado por una tormenta de citoquinas puede generar falla multiorgánica y explicar algunas manifestaciones cardíacas. Las principales asociaciones al sistema cardiovascular reportadas en la infección por COVID-19 son el síndrome coronario agudo, la falla cardiaca aguda, el choque cardiogénico y las arritmias. La pericarditis aguda es un síndrome inflamatorio de etiología principalmente viral, pero su relación con la infección por SARS-COV2 parece ser infrecuente, con pocos reportes en la literatura. Se presenta el caso de una paciente que desarrolló pericarditis concomitante a la infección por SARS-COV2. Mención de responsabilidad : Jhon Edwar García-Rueda, Ana María Caicedo-Bolaños, Luz Adriana Gómez-Ramírez, Jorge Ricardo Sánchez-Madrid Referencia : Iatreia ; 35(1):74-78, 2022. DOI (Digital Object Identifier) : 10.17533/udea.iatreia.130 Derechos de uso : CC BY-NC-SA En línea : https://revistas.udea.edu.co/index.php/iatreia/article/view/345585 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5819 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001753 AC-2021-069 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2021-069Adobe Acrobat PDF Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) / Laura Fernanda Niño Serna ; Carolina Giraldo Alzate
Título : Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) Tipo de documento : documento electrónico Autores : Laura Fernanda Niño Serna, ; Carolina Giraldo Alzate, Fecha de publicación : 2021 Títulos uniformes : BMC Pediatrics Idioma : Inglés (eng) Palabras clave : Sepsis SARS-CoV2 PIMS-TS infammatory mortality Resumen : Background: The clinical presentation and severity of Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) is widespread and presents a very low mortality rate in high-income countries. This research describes the clinical characteristics of MIS-C in critically ill children in middle-income countries and the factors associated with the rate of mortality and patients with critical outcomes. Methods: An observational cohort study was conducted in 14 pediatric intensive care units (PICUs) in Colombia between April 01, 2020, and January 31, 2021. Patient age ranged between one month and 18 years, and each patient met the requirements set forth by the World Health Organization (WHO) for MIS-C. Results: There were seventy-eight children in this study. The median age was seven years (IQR 1-11), 18 % (14/78) were under one year old, and 56 % were male. 35 % of patients (29/78) were obese or overweight. The PICU stay per individual was six days (IQR 4-7), and 100 % had a fever upon arrival to the clinic lasting at least five days (IQR 3.7-6). 70 % (55/78) of patients had diarrhea, and 87 % (68/78) had shock or systolic myocardial dysfunction (78 %). Coronary aneurysms were found in 35 % (27/78) of cases, and pericardial effusion was found in 36 %. When compared to existing data in high-income countries, there was a higher mortality rate observed (9 % vs. 1.8 %; p=0.001). When assessing the group of patients that did not survive, a higher frequency of ferritin levels was found, above 500 ngr/mL (100 % vs. 45 %; p=0.012), as well as more cardiovascular complications (100 % vs. 54 %; p = 0.019) when compared to the group that survived. The main treatments received were immunoglobulin (91 %), vasoactive support (76 %), steroids (70.5 %) and antiplatelets (44 %). Conclusions: Multisystem Inflammatory Syndrome in Children due to SARS-CoV-2 in critically ill children living in a middle-income country has some clinical, laboratory, and echocardiographic characteristics similar to those described in high-income countries. The observed inflammatory response and cardiovascular involvement were conditions that, added to the later presentation, may explain the higher mortality seen in these children. Mención de responsabilidad : Lorena Acevedo, Byron Enrique Piñeres-Olave, Laura Fernanda Niño-Serna, Liliana Mazzillo Vega, Ivan Jose Ardila Gomez, Shayl Chacón, Juan Camilo Jaramillo-Bustamante, Hernando Mulett-Hoyos, Otto González-Pardo, Eliana Zemanate, Ledys Izquierdo, Jaime Piracoca Mejìa, Jose Luis Junco González, Beatriz Giraldo Duran, Carolina Bonilla Gonzalez, Helen Preciado, Rafael Orozco Marun, Martha I Alvarez-Olmos, Carolina Giraldo Alzate, Jorge Rojas, Juan Carlos Salazar-Uribe, Juan-Manuel Anaya & Jaime Fernández-Sarmiento Referencia : BMC Pediatr. 2021 Nov 18;21(1):516. DOI (Digital Object Identifier) : 10.1186/s12887-021-02974-9 PMID : 34794410 Derechos de uso : CC BY En línea : https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-021-02974-9 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5839 Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) [documento electrónico] / Laura Fernanda Niño Serna, ; Carolina Giraldo Alzate, . - 2021.
Obra : BMC Pediatrics
Idioma : Inglés (eng)
Palabras clave : Sepsis SARS-CoV2 PIMS-TS infammatory mortality Resumen : Background: The clinical presentation and severity of Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) is widespread and presents a very low mortality rate in high-income countries. This research describes the clinical characteristics of MIS-C in critically ill children in middle-income countries and the factors associated with the rate of mortality and patients with critical outcomes. Methods: An observational cohort study was conducted in 14 pediatric intensive care units (PICUs) in Colombia between April 01, 2020, and January 31, 2021. Patient age ranged between one month and 18 years, and each patient met the requirements set forth by the World Health Organization (WHO) for MIS-C. Results: There were seventy-eight children in this study. The median age was seven years (IQR 1-11), 18 % (14/78) were under one year old, and 56 % were male. 35 % of patients (29/78) were obese or overweight. The PICU stay per individual was six days (IQR 4-7), and 100 % had a fever upon arrival to the clinic lasting at least five days (IQR 3.7-6). 70 % (55/78) of patients had diarrhea, and 87 % (68/78) had shock or systolic myocardial dysfunction (78 %). Coronary aneurysms were found in 35 % (27/78) of cases, and pericardial effusion was found in 36 %. When compared to existing data in high-income countries, there was a higher mortality rate observed (9 % vs. 1.8 %; p=0.001). When assessing the group of patients that did not survive, a higher frequency of ferritin levels was found, above 500 ngr/mL (100 % vs. 45 %; p=0.012), as well as more cardiovascular complications (100 % vs. 54 %; p = 0.019) when compared to the group that survived. The main treatments received were immunoglobulin (91 %), vasoactive support (76 %), steroids (70.5 %) and antiplatelets (44 %). Conclusions: Multisystem Inflammatory Syndrome in Children due to SARS-CoV-2 in critically ill children living in a middle-income country has some clinical, laboratory, and echocardiographic characteristics similar to those described in high-income countries. The observed inflammatory response and cardiovascular involvement were conditions that, added to the later presentation, may explain the higher mortality seen in these children. Mención de responsabilidad : Lorena Acevedo, Byron Enrique Piñeres-Olave, Laura Fernanda Niño-Serna, Liliana Mazzillo Vega, Ivan Jose Ardila Gomez, Shayl Chacón, Juan Camilo Jaramillo-Bustamante, Hernando Mulett-Hoyos, Otto González-Pardo, Eliana Zemanate, Ledys Izquierdo, Jaime Piracoca Mejìa, Jose Luis Junco González, Beatriz Giraldo Duran, Carolina Bonilla Gonzalez, Helen Preciado, Rafael Orozco Marun, Martha I Alvarez-Olmos, Carolina Giraldo Alzate, Jorge Rojas, Juan Carlos Salazar-Uribe, Juan-Manuel Anaya & Jaime Fernández-Sarmiento Referencia : BMC Pediatr. 2021 Nov 18;21(1):516. DOI (Digital Object Identifier) : 10.1186/s12887-021-02974-9 PMID : 34794410 Derechos de uso : CC BY En línea : https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-021-02974-9 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5839 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001773 AC-2021-089 Archivo digital Producción Científica Artículos científicos Disponible